Concepedia

Leanne Dyal

LD

Statistics

Publications

26

Citations

9K

H-Index

23

Active since

2008

Affiliations

Population Health Research Institute(Current)

McMaster University

University of Edinburgh

Hamilton Health Sciences

University of Washington

Leanne Dyal is an author at Population Health Research Institute specializing in medicine, pharmacotherapy, and cardiovascular pharmacotherapy.

Publications per year

2008–2021

26

Publications

26

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

Johannes F.E. Mann, Roland E. Schmieder, Matthew McQueen et al. · The Lancet · 2008 · 1.6K citations

, , +12

Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

Hertzel C. Gerstein, Naveed Sattar, Julio Rosenstock et al. · New England Journal of Medicine · 2021 · 777 citations · Full text

, , +16

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

, , +13

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

1–5 of 26